The effects of the glutamate antagonist memantine on brain activation to an auditory perception task

Human Brain Mapping

Volumn 30, Issue 11, 2009, Pages 3616-3624

  Van Wageningen, Heidi ^a   Jørgensen, Hugo A ^a,b   Specht, Karsten ^a,b   Eichele, Tom ^a   Hugdahl, Kenneth ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cognitive functions; fMRI; Glutamate; ICA; Memantine; NMDA receptor

Indexed keywords

EBIXIA; GLUTAMATE RECEPTOR ANTAGONIST; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGITATION; ANXIETY; ARTICLE; COGNITION; CONFUSION; CONTROLLED STUDY; CYSTITIS; DIZZINESS; DROWSINESS; DRUG EFFECT; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HALLUCINATION; HEADACHE; HEARING; HUMAN; HUMAN EXPERIMENT; INDEPENDENT COMPONENT ANALYSIS; INSOMNIA; LIBIDO; MALE; MUSCLE HYPERTONIA; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; VOMITING;

ACOUSTIC STIMULATION; ADULT; AUDITORY PERCEPTION; BRAIN; BRAIN MAPPING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MEMANTINE; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PRINCIPAL COMPONENT ANALYSIS; YOUNG ADULT;

EID: 70350310106     PISSN: 10659471     EISSN: None     Source Type: Journal    
DOI: 10.1002/hbm.20789     Document Type: Article

References (61)

1. Abel KM, Allin MP, Kucharska-Pietura K, Andrew C, Williams S, David AS, Phillips ML (2003a): Ketamine and fMRI BOLD signal: Distinguishing between effects mediated by change in blood flow versus change in cognitive state. Hum Brain Mapp 18:135-145. (Pubitemid 36150933)
2. Abel KM, Allin MP, Kucharska-Pietura K, David A, Andrew C, Williams S, Brammer MJ, Phillips ML (2003b): Ketamine alters neural processing of facial emotion recognition in healthy men: An fMRI study. Neuroreport 14:387-391. (Pubitemid 36337936)
3. Aracava Y, Pereira EF, Maelicke A, Albuquerque EX (2005): Memantine blocks α7* nicotinic acetylcholine receptors more potently than N-methyl-D-aspartate receptors in rat hippocampal neurons. J Pharmacol Exp Ther 312:1195-1205. (Pubitemid 40293781)
4. Areosa SA, Sherriff F, McShane R (2005): Memantine for dementia. Cochrane Database Syst Rev 3:CD003154.
5. Ashburner J, Friston KJ (1999): Nonlinear spatial normalization using basis functions. Hum Brain Mapp 7:254-266. (Pubitemid 29269964)
6. Beal MF (1995): Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357-366.
7. Bell AJ, Sejnowski TJ (1995): An information-maximization approach to blind separation and blind deconvolution. Neural Comput 7:1129-1159.
8. Binder JR, Frost JA, Hammeke TA, Bellgowan PS, Springer JA, Kaufman JN, Possing ET (2000): Human temporal lobe activation by speech and nonspeech sounds. Cereb Cortex 10:512-528.
9. Buisson B, Bertrand D (1998): Open-channel blockers at the human α4β2 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 53:555-563. (Pubitemid 28162880)
10. Bush G, Luu P, Posner MI (2000): Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4:215-222. (Pubitemid 30332147)
11. Bustos G, Abarca J, Forray MI, Gysling K, Bradberry CW, Roth RH (1992): Regulation of excitatory amino acid release by N-methyl- D-aspartate receptors in rat striatum: In vivo microdialysis studies. Brain Res 585(1-2):105-115.
12. Calhoun V, Adali T (2006): Unmixing fMRI with independent component analysis. IEEE Eng Med Biol Mag 25:79-90.
13. Calhoun VD, Adali T, Pearlson GD, Pekar JJ (2001): A method for making group inferences from functional MRI data using independent component analysis. Hum Brain Mapp 14:140-151. (Pubitemid 33032347)
14. Chen HS, Lipton SA (2006): The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem 97:1611-1626.
15. Cooper JR, Bloom FE, Roth RH (2002): The Biochemical Basis of Neuropharmacology, 8th ed. USA: Oxford University Press.
16. Corlett PR, Honey GD, Aitken MR, Dickinson A, Shanks DR, Absalom AR, Lee M, Pomarol-Clotet E, Murray GK, McKenna PJ, Robbins TW, Bullmore ET, Fletcher PC (2006): Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: Linking cognition, brain activity, and psychosis. Arch Gen Psychiatry 63:611-621.
17. Cull-Candy S, Brickley S, Farrant M (2001): NMDA receptor subunits: Diversity, development and disease. Curr Opin Neurobiol 11:327-335. (Pubitemid 32524098)
18. Danysz W, Parsons CG, Mobius HJ, Stoffler A, Quack G (2000): Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease-A unified glutamatergic hypothesis on the mechanism of action. Neurotox Res 2(2-3):85-97.
19. Deakin JF, Lees J, McKie S, Hallak JE, Williams SR, Dursun SM (2008): Glutamate and the neural basis of the subjective effects of ketamine: A pharmacomagnetic resonance imaging study. Arch Gen Psychiatry 65:154-164. (Pubitemid 351214314)
20. Eichele T, Specht K, Moosmann M, Jongsma ML, Quiroga RQ, Nordby H, Hugdahl K (2005): Assessing the spatiotemporal evolution of neuronal activation with single-trial event-related potentials and functional MRI. Proc Natl Acad Sci USA 102:17798-17803. (Pubitemid 41803577)
21. Esposito F, Bertolino A, Scarabino T, Latorre V, Blasi G, Popolizio T, Tedeschi G, Cirillo S, Goebel R, Di Salle F (2006): Independent component model of the default-mode brain function: Assessing the impact of active thinking. Brain Res Bull 70(4-6):263-269. (Pubitemid 44508789)
22. Fu CH, Abel KM, Allin MP, Gasston D, Costafreda SG, Suckling J, Williams SC, McGuire PK (2005): Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: A functional magnetic resonance imaging study. Psychopharmacology (Berl) 183:92-102. (Pubitemid 41484186)
23. Green MF (1998): Schizophrenia from a Neurocognitive Perspective. Boston: Allyn & Bacon.
24. Hall DA, Haggard MP, Akeroyd MA, Palmer AR, Summerfield AQ, Elliott MR, Gurney EM, Bowtell RW (1999): "Sparse" temporal sampling in auditory fMRI. Hum Brain Mapp 7:213-223.
25. Heinrichs RW (2000): In Search of Madness. Schizophrenia and Neuroscience. New York: Oxford University Press.
26. Hergovich N, Singer E, Agneter E, Eichler HG, Graselli U, Simhandl C, Jilma B (2001): Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men: A randomized, double-blind, placebo-controlled trial. Neuropsychopharmacology 24:590-593. (Pubitemid 32244319)
27. Herrling PL (1992): Synaptic physiology of excitatory amino acids. Arzneimittelforschung 42(2A):202-208.
28. Honey RA, Honey GD, O'Loughlin C, Sharar SR, Kumaran D, Bullmore ET, Menon DK, Donovan T, Lupson VC, Bisbrown- Chippendale R, Fletcher PC (2004): Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: An FMRI study. Neuropsychopharmacology 29:1203-1214. (Pubitemid 38670056)
29. Hugdahl K (2003): Dichotic listening in the study of auditory laterality. In: Hugdahl K, Davidson RJ, editors. The Asymmetrical Brain. Cambridge, MA: MIT Press. pp. 441-476.
30. Hugdahl K, Bronnick K, Kyllingsbaek S, Law I, Gade A, Paulson OB (1999): Brain activation during dichotic presentations of consonant-vowel and musical instrument stimuli: A 15O-PET study. Neuropsychologia 37:431-440. (Pubitemid 29138926)
31. Hugdahl K, Law I, Kyllingsbaek S, Bronnick K, Gade A, Paulson OB (2000): Effects of attention on dichotic listening: An 15O-PET study. Hum Brain Mapp 10:87-97. (Pubitemid 30390292)
32. Hugdahl K, Westerhausen R, Alho K, Medvedev S, Laine M, Hamalainen H (2008): Attention and cognitive control: Unfolding the dichotic listening story. Scand J Psychol 50:11-22.
33. Hugdahl K, Westerhausen R, Alho K, Medvedev S, Laine M, Hamalainen H (2009): Attention and cognitive control: Unfolding the dichotic listening story. Scand J Psychol 50:11-22.
34. Jancke L, Shah NJ (2002): Does dichotic listening probe temporal lobe functions? Neurology 58:736-743.
35. Kiehl KA, Stevens MC, Laurens KR, Pearlson G, Calhoun VD, Liddle PF (2005): An adaptive reflexive processing model of neurocognitive function: Supporting evidence from a large scale (n = 100) fMRI study of an auditory oddball task. Neuroimage 25:899-915. (Pubitemid 40461728)
36. Korostenskaja M, Nikulin VV, Kicic D, Nikulina AV, Kahkonen S (2007): Effects of NMDA receptor antagonist memantine on mismatch negativity. Brain Res Bull 72(4-6):275-283. (Pubitemid 46602746)
37. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994): Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214.
38. Liu J, Moghaddam B (1995): Regulation of glutamate efflux by excitatory amino acid receptors: Evidence for tonic inhibitory and phasic excitatory regulation. J Pharmacol Exp Ther 274:1209-1215.
39. Malinen S, Hlushchuk Y, Hari R (2007): Towards natural stimulation in fMRI-Issues of data analysis. Neuroimage 35:131-139. (Pubitemid 46242200)
40. Miller EK, Cohen JD (2001): An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24:167-202. (Pubitemid 32695227)
41. Moghaddam B, Adams B, Verma A, Daly D (1997): Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927. (Pubitemid 27155025)
42. Northoff G, Richter A, Bermpohl F, Grimm S, Martin E, Marcar VL, Wahl C, Hell D, Boeker H (2005): NMDA hypofunction in the posterior cingulate as a model for schizophrenia: An exploratory ketamine administration study in fMRI. Schizophr Res 72(2-3):235-248. (Pubitemid 39550994)
43. Olney JW, Newcomer JW, Farber NB (1999): NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33:523-533.
44. Parsons CG, Danysz W, Quack G (1999): Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - A review of preclinical data. Neuropharmacology 38:735-767. (Pubitemid 29187336)
45. Raczkowski D, Kalat JW, Nebes R (1974): Reliability and validity of some handedness questionnaire items. Neuropsychologia 12:43-47.
46. Rammes G, Rupprecht R, Ferrari U, Zieglgansberger W, Parsons CG (2001): The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Lett 306(1-2):81-84.
47. Rammsayer TH (2001): Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans. Learn Mem 8:20-25.
48. Rimol LM, Specht K, Weis S, Savoy R, Hugdahl K (2005): Processing of sub-syllabic speech units in the posterior temporal lobe: An fMRI study. Neuroimage 26:1059-1067. (Pubitemid 40806484)
49. Robinson DM, Keating GM (2006): Memantine: A review of its use in Alzheimer's disease. Drugs 66:1515-1534. (Pubitemid 44250755)
50. Rogawski MA, Wenk GL (2003): The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Rev 9:275-308. (Pubitemid 37254706)
51. Rund BR, Sundet K, Asbjornsen A, Egeland J, Landro NI, Lund A, Roness A, Stordal KI, Hugdahl K (2006): Neuropsychological test profiles in schizophrenia and non-psychotic depression. Acta Psychiatr Scand 113:350-359.
52. Schugens MM, Egerter R, Daum I, Schepelmann K, Klockgether T, Loschmann PA (1997): The NMDA antagonist memantine impairs classical eyeblink conditioning in humans. Neurosci Lett 224:57-60. (Pubitemid 27112869)
53. Schulz H, Jobert M, Coppola R, Herrmann WM, Pantev M (1996): The use of diurnal vigilance changes in the EEG to verify vigilance- enhancing effects of memantine in a clinical pharmacological study. Neuropsychobiology 33:32-40. (Pubitemid 26026674)
54. Seifritz E, Esposito F, Hennel F, Mustovic H, Neuhoff JG, Bilecen D, Tedeschi G, Scheffler K, Di Salle F (2002): Spatiotemporal pattern of neural processing in the human auditory cortex. Science 297:1706-1708. (Pubitemid 35000786)
55. Specht K, Reul J (2003): Functional segregation of the temporal lobes into highly differentiated subsystems for auditory perception: An auditory rapid event-related fMRI-task. Neuroimage 20:1944-1954. (Pubitemid 37543613)
56. Specht K, Huber W, Willmes K, Shah NJ, Jancke L (2008): Tracing the ventral stream for auditory speech processing in the temporal lobe by using a combined time series and independent component analysis. Neurosci Lett 442:180-185.
57. Study MRZ 90001-2040, SM (1985): Study MRZ 90001-92040 Dose-effect relationship of Aktinol-Memantine on the cardiovascular function of 6 healthy volunteers.
58. Stuss DT, Alexander MP, Floden D, Binns MA, Levine B, McIntosh AR (2002): Fractionation and localization of distinct frontal lobe processes: Evidence from focal lesions in humans. In: Stuss DT, Knight RT, editors. Principles of Frontal Lobe Function. New York: Oxford University Press. pp 392-407.
59. Theberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N, Schaefer B, Densmore M, Drost DJ (2003): Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am J Psychiatry 160:2231-2233. (Pubitemid 39619619)
60. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT (1995): Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 52:829-836.
61. van den Noort M, Specht K, Rimol LM, Ersland L, Hugdahl K (2008): A new verbal reports fMRI dichotic listening paradigm for studies of hemispheric asymmetry. Neuroimage 40:902-911.